Facial lipoatrophy: appearances are not deceiving
Sanches, R.S.; Mill, J.; Machado, A.A.; Donadi, E.A.; Morais Fernandes, A.P.
Journal of the Association of Nurses in Aids Care Janac 20(3): 169-175
2009
ISSN/ISBN: 1552-6917 PMID: 19427594 DOI: 10.1016/j.jana.2009.01.002Document Number: 206559
Lipodystrophy syndrome (LS) has been reported as visible markers that can identify HIV status. Changes in body shape are detrimental in terms of psychological welfare and may affect well-being and increase the stigma associated with HIV disease. In the current study, the psychosocial impact of LS was evaluated. A total of 84 HIV-infected patients receiving antiretroviral therapy and exhibiting dyslipidemia were interviewed in an urban hospital setting in Brazil in 2006 using a standardized questionnaire. Of the 84 patients exhibiting dyslipidemia, 40 patients also exhibited body changes, and of these, 25 had facial lipoatrophy. From a psychosocial perspective, patients presenting with facial lipoatrophy reported alterations in self-image and self-esteem and believed that other people noticed their body changes. The results are relevant for nurses who need to be well-prepared to recognize lipodystrophy, to implement nursing interventions including lifestyle changes, and to provide psychosocial support to patients with LS.
Document emailed within 0-6 h
